References
- World Health Organization. Immunization policy. Global programme for vaccines and immunization. Expanded Programme on Immunization. Available from: http://whqlibdoc.who.int/hq/1995/WHO_EPI_GEN_95.03_Rev.1.pdf. Accessed 22 May 2011.
- World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record). Wkly Epidemiol Rec 2006; 81:445 - 52; PMID: 17124755
- World Health Organization. Global Immunization Data. 2010 Dec; Available from: http://www.who.int/immunization_monitoring/Global_Immunization_Data.pdf Accessed 22 May 2011.
- Marshall GS, Happe LE, Lunacsek OE, Szymanski MD, Woods CR, Zahn M, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007; 26:496 - 500; http://dx.doi.org/10.1097/INF.0b013e31805d7f17; PMID: 17529866
- Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt H-J, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006; 25:507 - 12; http://dx.doi.org/10.1097/01.inf.0000222413.47344.23; PMID: 16732148
- World Health Organization. Inactivated poliovirus vaccine following oral poliovirus vaccine cessation. Wkly Epidemiol Rec 2006; 81:137 - 44; PMID: 16673508
- Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, et al. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Pediatr Infect Dis J 2009; 28:Suppl S97 - 108; http://dx.doi.org/10.1097/INF.0b013e318199f61b; PMID: 19325452
- Dagan R, Poolman JT, Zepp F. Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates. Expert Rev Vaccines 2008; 7:97 - 115; http://dx.doi.org/10.1586/14760584.7.1.97; PMID: 18251697
- Gatchalian S, Reyes M, Bermal N, Chandrasekaran V, Han HH, Bock HL, et al. A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life. Hum Vaccin 2008; 4:60 - 6; http://dx.doi.org/10.4161/hv.4.1.5069; PMID: 18376148
- Gatchalian SR, Ramakrishnan G, Bock HL, Lefevre I, Jacquet JM. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children. Hum Vaccin 2010; 6:664 - 72; http://dx.doi.org/10.4161/hv.6.8.12155; PMID: 20657177
- Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, et al, Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 2001; 345:656 - 61; http://dx.doi.org/10.1056/NEJMoa003077; PMID: 11547719
- Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981; 68:650 - 60; PMID: 7031583
- World Health Organization. Standard Procedure for Determining Immunity to Poliovirus using the Microneutralisation Test. 1993 WHO/EPI/GEN 93 9.